Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576381 · ClinicalTrials.gov registry record · Phase 1
Understanding Dexmedetomidine in Neonates After Open Heart Surgery
A Phase 1 study of Tetrology of Fallot and Heart Ventricle, sponsored by Athena Zuppa.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00576381 is a Phase 1 study of Tetrology of Fallot and Heart Ventricle that has completed, run by Athena Zuppa. The registered enrollment target is 30 participants, below the 82-participant average among 3 other Tetrology of Fallot trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00576381, a Phase 1 study of Tetrology of Fallot and Heart Ventricle, has completed, sponsored by Athena Zuppa.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine what happens to dexmedetomidine in the body after it has been given to a newborn after heart surgery. We want to learn how long the drug stays in the body, how the drug is metabolized by the body, and how well the medicine works at a particular dose or amount.
Conditions Studied
Interventions
- DRUG Dexmedetomidine
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-04 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576381
The ClinicalTrials.gov registry entry for NCT00576381 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 82-participant average among 3 other Tetrology of Fallot trials with a reported enrollment target (63% lower). The listed sponsor is Athena Zuppa, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Tetrology of Fallot appearing as the primary indexed condition, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT00576381 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00576381 about?
NCT00576381 is a clinical study titled "Understanding Dexmedetomidine in Neonates After Open Heart Surgery". The purpose of this study is to determine what happens to dexmedetomidine in the body after it has been given to a newborn after heart surgery. We want to learn how long the drug stays in the body, how the drug is metabolized by the body, and how well the medicine works at a particular dose or amoun...
What is the current status of trial NCT00576381?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2006-04. Estimated completion is 2010-12.
What conditions does trial NCT00576381 study?
This clinical trial studies the following conditions: Tetrology of Fallot, Heart Ventricle, Hypoplastic Left Heart.
What interventions are being tested in trial NCT00576381?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00576381?
This trial is sponsored by Athena Zuppa, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00576381 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetrology of Fallot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.